Literature DB >> 20070693

Clostridium difficile in solid organ transplant recipients.

E R Dubberke1, D J Riddle.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 20070693      PMCID： PMC3899697          DOI： 10.1111/j.1600-6143.2009.02891.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  35 in total

Review 1.  Clostridium difficile testing: after 20 years, still challenging.

Authors:  Tracy D Wilkins; David M Lyerly
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

2.  Intravenous metronidazole and Clostridium difficile-associated diarrhea or colitis.

Authors:  S Johnson; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

3.  Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.

Authors:  Ramsey M Dallal; Brian G Harbrecht; Arthur J Boujoukas; Carl A Sirio; Linda M Farkas; Kenneth K Lee; Richard L Simmons
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

4.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

5.  Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea.

Authors:  J K Shim; S Johnson; M H Samore; D Z Bliss; D N Gerding
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

6.  Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

Authors:  Johannes Aas; Charles E Gessert; Johan S Bakken
Journal:  Clin Infect Dis       Date:  2003-02-14       Impact factor: 9.079

7.  High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital.

Authors:  Scott R Curry; Jane W Marsh; Kathleen A Shutt; Carlene A Muto; Mary M O'Leary; Melissa I Saul; A William Pasculle; Lee H Harrison
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

8.  Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea.

Authors:  Mark H Wilcox
Journal:  J Antimicrob Chemother       Date:  2004-04-08       Impact factor: 5.790

Review 9.  Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature.

Authors:  Anucha Apisarnthanarak; Behzad Razavi; Linda M Mundy
Journal:  Clin Infect Dis       Date:  2002-08-26       Impact factor: 9.079

10.  Risk factors for Clostridium difficile infection.

Authors:  G E Bignardi
Journal:  J Hosp Infect       Date:  1998-09       Impact factor: 3.926
View more
  13 in total

Review 1.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

Review 2.  Epidemiology of Clostridium difficile infection.

Authors:  Daryl D Depestel; David M Aronoff
Journal:  J Pharm Pract       Date:  2013-10

3.  Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.

Authors:  Yao-Wen Cheng; Emmalee Phelps; Vincent Ganapini; Noor Khan; Fangqian Ouyang; Huiping Xu; Sahil Khanna; Raseen Tariq; Rachel J Friedman-Moraco; Michael H Woodworth; Tanvi Dhere; Colleen S Kraft; Dina Kao; Justin Smith; Lien Le; Najwa El-Nachef; Nirmal Kaur; Sree Kowsika; Adam Ehrlich; Michael Smith; Nasia Safdar; Elizabeth Ann Misch; Jessica R Allegretti; Ann Flynn; Zain Kassam; Asif Sharfuddin; Raj Vuppalanchi; Monika Fischer
Journal:  Am J Transplant       Date:  2018-08-31       Impact factor: 8.086

4.  Outcomes of Clostridium difficile infection in recipients of solid abdominal organ transplants.

Authors:  Jennifer L Hsu; James J Enser; Trevor McKown; Glen E Leverson; John D Pirsch; Timothy M Hess; Nasia Safdar
Journal:  Clin Transplant       Date:  2014-01-30       Impact factor: 2.863

5.  Clostridium difficile infection after pediatric solid organ transplantation: a practical single-center experience.

Authors:  Christian Breuer; Sabrina Döring; Holger Rohde; Stefan Rutkowski; Ingo Müller; Jun Oh
Journal:  Pediatr Nephrol       Date:  2019-03-06       Impact factor: 3.714

Review 6.  Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients.

Authors:  Nirja Mehta; Tiffany Wang; Rachel J Friedman-Moraco; Cynthia Carpentieri; Aneesh K Mehta; Nadine Rouphael; Tanvi Dhere; Christian P Larsen; Colleen S Kraft; Michael H Woodworth
Journal:  J Clin Microbiol       Date:  2021-06-16       Impact factor: 11.677

7.  The Effect of Lactobacillus plantarum 299v on the Incidence of Clostridium difficile Infection in High Risk Patients Treated with Antibiotics.

Authors:  Agata Kujawa-Szewieczek; Marcin Adamczak; Katarzyna Kwiecień; Sylwia Dudzicz; Magdalena Gazda; Andrzej Więcek
Journal:  Nutrients       Date:  2015-12-04       Impact factor: 5.717

8.  Enhanced Efficacy of High Dose Oral Vancomycin Therapy in Clostridium difficile Diarrhea for Hospitalized Adults Not Responsive to Conventional Oral Vancomycin Therapy: Antibiotic Stewardship Implications.

Authors:  Burke A Cunha; Julia Sessa; Sharon Blum
Journal:  J Clin Med       Date:  2018-04-10       Impact factor: 4.241

Review 9.  Recent advances in understanding and managing infectious diseases in solid organ transplant recipients.

Authors:  Claire Aguilar; Shahid Husain; Olivier Lortholary
Journal:  F1000Res       Date:  2018-05-24

10.  Evaluation of risk factors for a fulminant Clostridium difficile infection after cardiac surgery: a single-center, retrospective cohort study.

Authors:  Maximilian Vondran; Senta Schack; Jens Garbade; Christian Binner; Meinhard Mende; Ardawan Julian Rastan; Michael Andrew Borger; Thomas Schroeter
Journal:  BMC Anesthesiol       Date:  2018-09-27       Impact factor: 2.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.